Reaction
Pilonidal Disease reporting signals
As of the last recalculation, Pilonidal Disease appears in 235 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is INFLIXIMAB-DYYB (PRR 69.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Infliximab-Dyyb | 21 | 69.8 | 69.8 |
| Testosterone | 17 | 69.4 | 69.4 |
| Bimekizumab | 7 | 30.0 | 30.0 |
| Emicizumab | 4 | 29.2 | 29.2 |